Surgical treatment of pilomatrix carcinoma: a systematic review

Hannah R. Riva,Nehaa Sohail,Mojahed Mohammad K. Shalabi,Benjamin Kelley,Cary Chisholm,Stanislav N. Tolkachjov
DOI: https://doi.org/10.1111/ijd.17596
2024-12-06
International Journal of Dermatology
Abstract:Pilomatrix carcinoma (PMC), also known as pilomatrical carcinoma, is a rare, malignant tumor of the hair follicle that may arise from a benign pilomatricoma or de novo and carries a high risk of recurrence and metastasis. This study sought to investigate and compare surgical modalities for PMC, including reported outcomes and recurrence rates. In July 2024, a systematic review of PubMed, Embase, and Web of Science databases on surgical modalities and PMC was conducted. Randomized controlled trials and observational studies were included. The search yielded 257 articles; after the application of inclusion and exclusion criteria, 50 articles were included: four case series and 46 case reports with a total of 101 cases. There were 17 cases treated with Mohs micrographic surgery (MMS) with no recurrences. There were 84 cases treated with surgical excision with an overall recurrence rate of 34.5%. The mean follow‐up time was 7.5 months for MMS and 7.6 months for surgical excision. MMS showed excellent outcomes for PMC with no recurrences compared with a recurrence rate of 34.5% for surgical excision (P
dermatology
What problem does this paper attempt to address?